IP Library Granted Patent US 8,557,599
Granted Patent B2
US 8,557,599 · App. 13/323,561 · Granted Oct 15, 2013

Method for automatic determination of sample

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,557,599
App. No.
13/323,561
Granted
Oct 15, 2013
Kind
B2
Abstract

A method of determining a kind of a sample, in a method for analyzing a substance by the steps of supplying the sample to be analyzed to a reaction system by a supplying means comprising a transparent region composed of a transparent material, reacting a reagent for detecting the substance with the sample in the reaction system, and analyzing a signal derived from a product obtained by the reaction, characterized by irradiating the transparent region with light in the supplying step, and analyzing an optical intensity of the light.

Claims (15)

1. A method for analyzing a substance, comprising a supplying step and an analyzing step,

the supplying step comprising the steps of:

supplying a sample suspected of containing the substance to be analyzed to a reaction system by a supplying means comprising a transparent region composed of a transparent material, wherein the sample is selected from the group consisting of whole blood, a serum, and plasma,

irradiating the transparent region with light, and

measuring an optical intensity T of a transmitted light from the transparent region,

the analyzing step comprising the steps of:

reacting a reagent for detecting the substance with the sample in the reaction system, and

analyzing a signal derived from a product obtained by the reaction,

wherein the supplying means is one in which a tip comprising the transparent region is mounted, or a tube or a channel comprising the transparent region, and the transparent region exhibits a lens effect that an optical intensity when plasma or a serum is aspirated into the transparent region is higher than an optical intensity when no sample is aspirated into the transparent region, and

wherein after the measuring step in the supplying step, the supplying step further includes the steps of:

(A) comparing the optical intensity T with previously determined threshold a between an optical intensity when plasma or a serum is aspirated into the supplying means and an optical intensity when no sample is aspirated into the supplying means, and with previously determined threshold b between an optical intensity when no sample is aspirated into the supplying means and an optical intensity when whole blood is aspirated into the supplying means,

(B′) determining that, when the optical intensity T of the sample is higher than the threshold a, the sample is judged as plasma or a serum; when the optical intensity thereof is lower than the threshold b, the following step (C) is carried out; and when the optical intensity thereof is between the threshold a and the threshold b, the following step (D) is carried out,

(C) diluting the sample, and comparing the difference “T′−T” between an optical intensity T′ measured under the same conditions and the optical intensity T, with previously determined threshold c between the difference “T′−T” when a sample is a chyle plasma or serum sample and the difference “T′−T” when a sample is whole blood, to determine that, when the “T′−T” is larger than the threshold c, the sample is judged as a chyle plasma or serum sample; and when the difference “T′−T” is not more than the threshold c, the sample is judged as whole blood, and

(D) diluting the sample, and comparing the difference “T′−T” between the optical intensity T′ measured under the same conditions and the optical intensity T, with previously determined threshold d between the difference “T′−T” when a sample is a chyle plasma or serum sample and the difference “T′−T” when no sample is aspirated into the supplying means, to determine that, when the “T′−T” is larger than the threshold d, the sample is judged as a chyle plasma or serum sample; and when the difference “T′−T” is not more than the threshold d, it is judged that no sample is aspirated into the supplying means.

2. The method according to claim 1 , wherein the supplying means is a dispensing means in which a pipette tip can be mounted and liquid can be aspirated and poured out by means of the tip.

Assignments (5)
CHANGE OF ADDRESS Recorded Feb 25, 2024
From: LSI MEDIENCE CORPORATION
To: LSI MEDIENCE CORPORATION
Reel/Frame 066674/0958 →
COMPANY SPLIT Recorded Feb 25, 2024
From: LSI MEDIENCE CORPORATION
To: PHC CORPORATION
Reel/Frame 066675/0001 →
CHANGE OF NAME Recorded Feb 11, 2015
From: MITSUBISHI CHEMICAL MEDIENCE CORPORATION
To: LSI MEDIENCE CORPORATION
Reel/Frame 034947/0277 →
MERGER Recorded Jan 9, 2012
From: MITSUBISHI KAGAKU IATRON, INC.
To: MITSUBISHI CHEMICAL MEDIENCE CORPORATION
Reel/Frame 027499/0851 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 6, 2012
From: KOYATA, ATSUSHI; YOKOI, HIROYUKI
To: MITSUBISHI KAGAKU IATRON, INC.
Reel/Frame 027494/0620 →